These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 3896784)
1. Inactivation of Clostridium botulinum type A neurotoxin by trypsin and purification of two tryptic fragments. Proteolytic action near the COOH-terminus of the heavy subunit destroys toxin-binding activity. Shone CC; Hambleton P; Melling J Eur J Biochem; 1985 Aug; 151(1):75-82. PubMed ID: 3896784 [TBL] [Abstract][Full Text] [Related]
2. Botulinum neurotoxin type B. Its purification, radioiodination and interaction with rat-brain synaptosomal membranes. Evans DM; Williams RS; Shone CC; Hambleton P; Melling J; Dolly JO Eur J Biochem; 1986 Jan; 154(2):409-16. PubMed ID: 3753681 [TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of the ganglioside-binding fragment of Clostridium botulinum type E neurotoxin. Kamata Y; Kimura Y; Hiroi T; Sakaguchi G; Kozaki S Biochim Biophys Acta; 1993 Feb; 1156(2):213-8. PubMed ID: 8427878 [TBL] [Abstract][Full Text] [Related]
4. Pepsin fragmentation of botulinum type E neurotoxin: isolation and characterization of 112, 48, 46, and 16 kD fragments. Giménez JA; DasGupta BR J Protein Chem; 1992 Jun; 11(3):255-64. PubMed ID: 1388670 [TBL] [Abstract][Full Text] [Related]
5. Botulinum type A neurotoxin digested with pepsin yields 132, 97, 72, 45, 42, and 18 kD fragments. Gimenez JA; DasGupta BR J Protein Chem; 1993 Jun; 12(3):351-63. PubMed ID: 8397793 [TBL] [Abstract][Full Text] [Related]
6. Immunological characterization of papain-induced fragments of Clostridium botulinum type A neurotoxin and interaction of the fragments with brain synaptosomes. Kozaki S; Miki A; Kamata Y; Ogasawara J; Sakaguchi G Infect Immun; 1989 Sep; 57(9):2634-9. PubMed ID: 2668181 [TBL] [Abstract][Full Text] [Related]
7. Binding of Clostridium botulinum type C neurotoxin to rat brain synaptosomes. Agui T; Syuto B; Oguma K; Iida H; Kubo S J Biochem; 1983 Aug; 94(2):521-7. PubMed ID: 6630172 [TBL] [Abstract][Full Text] [Related]
8. Comparison of Clostridium botulinum toxins type D and C1 in molecular property, antigenicity and binding ability to rat-brain synaptosomes. Murayama S; Syuto B; Oguma K; Iida H; Kubo S Eur J Biochem; 1984 Aug; 142(3):487-92. PubMed ID: 6468375 [TBL] [Abstract][Full Text] [Related]
9. Botulinum neurotoxin type E fragmented with endoproteinase Lys-C reveals the site trypsin nicks and homology with tetanus neurotoxin. Giménez JA; DasGupta BR Biochimie; 1990 Apr; 72(4):213-7. PubMed ID: 2116911 [TBL] [Abstract][Full Text] [Related]
10. Botulinum type F neurotoxin. Large-scale purification and characterization of its binding to rat cerebrocortical synaptosomes. Wadsworth JD; Desai M; Tranter HS; King HJ; Hambleton P; Melling J; Dolly JO; Shone CC Biochem J; 1990 May; 268(1):123-8. PubMed ID: 2188647 [TBL] [Abstract][Full Text] [Related]
11. Binding ability of Clostridium botulinum neurotoxin to the synaptosome upon treatment of various kinds of the enzymes. Kitamura M; Sone S Biochem Biophys Res Commun; 1987 Mar; 143(3):928-33. PubMed ID: 3566763 [TBL] [Abstract][Full Text] [Related]
12. Localization of sites for 125I-labelled botulinum neurotoxin at murine neuromuscular junction and its binding to rat brain synaptosomes. Dolly JO; Williams RS; Black JD; Tse CK; Hambleton P; Melling J Toxicon; 1982; 20(1):141-8. PubMed ID: 7043781 [TBL] [Abstract][Full Text] [Related]
13. Characterization of Clostridium botulinum type B neurotoxin associated with infant botulism in japan. Kozaki S; Kamata Y; Nishiki T; Kakinuma H; Maruyama H; Takahashi H; Karasawa T; Yamakawa K; Nakamura S Infect Immun; 1998 Oct; 66(10):4811-6. PubMed ID: 9746583 [TBL] [Abstract][Full Text] [Related]
14. Immunological characterization of Clostridium butyricum neurotoxin and its trypsin-induced fragment by use of monoclonal antibodies against Clostridium botulinum type E neurotoxin. Kozaki S; Onimaru J; Kamata Y; Sakaguchi G Infect Immun; 1991 Jan; 59(1):457-9. PubMed ID: 1987060 [TBL] [Abstract][Full Text] [Related]
15. Properties of a protease-sensitive acceptor component in mouse brain synaptosomes for Clostridium botulinum type B neurotoxin. Ogasawara J; Kamata Y; Sakaguchi G; Kozaki S FEMS Microbiol Lett; 1991 Apr; 63(2-3):351-5. PubMed ID: 2060767 [TBL] [Abstract][Full Text] [Related]
16. Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin. Shone CC; Roberts AK Eur J Biochem; 1994 Oct; 225(1):263-70. PubMed ID: 7925446 [TBL] [Abstract][Full Text] [Related]
17. Clostridium butyricum neurotoxin: partial amino acid sequence of major proteolytic fragments and intracellular activity in PC12 cells. Giménez J; Lomneth R; DasGupta BR Toxicon; 1994 Sep; 32(9):1137-46. PubMed ID: 7801349 [TBL] [Abstract][Full Text] [Related]
18. Botulinum neurotoxin types B and E: purification, limited proteolysis by endoproteinase Glu-C and pepsin, and comparison of their identified cleaved sites relative to the three-dimensional structure of type A neurotoxin. Prabakaran S; Tepp W; DasGupta BR Toxicon; 2001 Oct; 39(10):1515-31. PubMed ID: 11478959 [TBL] [Abstract][Full Text] [Related]
19. Action of botulinum neurotoxin on acetylcholine release from rat brain synaptosomes: putative internalization of the toxin into synaptosomes. Murayama S; Umezawa J; Terajima J; Syuto B; Kubo S J Biochem; 1987 Dec; 102(6):1355-64. PubMed ID: 3129413 [TBL] [Abstract][Full Text] [Related]
20. The use of monoclonal antibodies to analyze the structure of Clostridium botulinum type E derivative toxin. Kozaki S; Kamata Y; Nagai T; Ogasawara J; Sakaguchi G Infect Immun; 1986 Jun; 52(3):786-91. PubMed ID: 2423459 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]